Neuro: Multiple System Atrophy: Free MSRA Podcast

🧠 FREE MSRA PODCAST – Multiple System Atrophy (MSA): High-Yield Revision Deep DiveToday’s episode unpacks Multiple System Atrophy — a challenging, exam-worthy topic for MSRA Neurology. Let’s break it down to the essentials: definition, diagnosis, differentiators, management, and must-know complications.📝 Key Learning Points📌 Definition• Rare, rapidly progressive neurodegenerative disorder• Affects multiple systems: autonomic dysfunction, Parkinsonism, cerebellar ataxia• Divided into MSA-P (Parkinsonism-dominant) and MSA-C (Cerebellar-dominant) subtypes📌 Pathology & Aetiology• Cause unknown; no clear risk factors• Key feature: abnormal accumulation of α-synuclein protein (forms glial cytoplasmic inclusions, GCIs) in brain support cells• Progressive loss of neurones in basal ganglia, cerebellum, and autonomic nervous system📌 Epidemiology• Rare (0.6 per 100,000 per year); more common in men• Onset: typically age 50–60• Much less common than Parkinson’s disease📌 Clinical Features & SubtypesMSA-P (Parkinsonian): • Rapidly progressive parkinsonism (bradykinesia, rigidity, postural instability) • Poor response to levodopa • Early, severe autonomic dysfunction: orthostatic hypotension, bladder dysfunction, erectile dysfunctionMSA-C (Cerebellar): • Gait/balance disturbance, limb incoordination, ataxic speech • Also has autonomic features: urinary/bowel problems, orthostatic hypotension• Early falls, dysphagia, stridor, sleep disturbance📌 Diagnosis & Differentials• Clinical diagnosis (no single test); postmortem confirmation is gold standard• Key Differentials: Parkinson’s disease, PSP, corticobasal degeneration, pure autonomic failure• Clues for MSA: poor levodopa response, rapid progression, early/severe autonomic dysfunction• I-123 MIBG scan: normal in MSA (vs reduced uptake in Parkinson’s)• MRI: atrophy in cerebellum/pons (may see "hot cross bun" sign)• Autonomic testing, urodynamics, sleep studies, swallowing assessments as needed📌 Management• No cure — focus on symptom relief, MDT input• Non-drug measures first for postural hypotension (compression stockings, increased salt/fluid)• Medications: midodrine/fludrocortisone for hypotension, antimuscarinics for bladder, trial of levodopa (often poor response)• Physiotherapy, speech/swallowing therapy, OT, psychological support• Water-based exercise, falls prevention, PEG feeding for nutrition if dysphagia📌 Prognosis & Complications• Progressive decline; average survival 7–10 years from onset• Factors for poorer prognosis: older age, early catheterisation, early severe autonomic failure• Complications: aspiration pneumonia, falls, respiratory issues, sudden death (autonomic dysfunction)• End-of-life care: symptom management, advanced planning, carer support📎 More MSRA Multiple System Atrophy Resources:📝 Notes: https://www.passthemsra.com/topic/multiple-system-atrophy-revision-notes/🧠 Flashcards: https://www.passthemsra.com/topic/multiple-system-atrophy-flashcards/💬 Accordion Q&A: https://www.passthemsra.com/topic/multiple-system-atrophy-accordion-qa-notes/🚀 Rapid Quiz: https://www.passthemsra.com/topic/multiple-system-atrophy-rapid-quiz/🧪 Quiz Bank: https://www.passthemsra.com/quizzes/multiple-system-atrophy/🎓 Neurology MSRA Course: https://www.passthemsra.com/courses/neurology-for-the-msra/#MSRA #MultipleSystemAtrophy #Neurology #MSRARevision #MSRAFlashcards #MSRAQuiz #MSRAAccordions #Neurodegeneration #PassTheMSRA